GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

6 Months Ended

Apr. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segment during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2023:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2022	$	1,743	$	1,953	$	256	$	3,952
Foreign currency translation impact	8		2		3		13
Goodwill arising from acquisitions and adjustments	—		15		—		15
Goodwill as of April 30, 2023	$	1,751	$	1,970	$	259	$	3,980

Components of other intangible assets during the period

The component parts of other intangible assets as of April 30, 2023 and October 31, 2022 are shown in the table below:

 

	Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2022
Purchased technology	$	1,733	$	1,068	$	665
Trademark/Tradename	196		148		48
Customer relationships	180		105		75
Backlog	8		8		—
Third-party technology and licenses	32		9		23
Total amortizable intangible assets	2,149		1,338		811
In-Process R&D	10		—		10
Total	$	2,159	$	1,338	$	821
As of April 30, 2023
Purchased technology	$	1,784	$	1,118	$	666
Trademark/Tradename	196		156		40
Customer relationships	182		122		60
Backlog	8		8		—
Third-party technology and licenses	33		11		22
Total amortizable intangible assets	2,203		1,415		788
In-Process R&D	10		—		10
Total	$	2,213	$	1,415	$	798

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2023	$	74
2024	$	133
2025	$	109
2026	$	80
2027	$	78
2028	$	71
Thereafter	$	243